For instance, patients with cholesteatoma exhibit higher concentrations of high-mobility group box 1 (HMGB1) carried by sEVs derived from plasma than are present in sEVs isolated from normal control plasma, suggesting their potential as a noninvasive biomarker for cholesteatoma [81]. Here, HMGB1 is linked to cholesteatoma.